-
UPDATE - Citi Downgrades CardioNet (BEAT) from Neutral to Sell; Patient Volume Targets Set to Miss
-
Morning Movers 6/1: EVVV, MCCC, PANL, HEV, PUK Higher; APC, WMG, BP, BEAT, DRQ, ATPG Lower
-
Notable Analyst Rating Changes 06/01: LVS, GENZ, V, CPT Upgraded; CNK, BEAT, GLW, AEO Downgraded
-
Citi Downgrades CardioNet (BEAT) to Sell
-
Unusual 11 Mid-Day Movers 7/1: OSK, BORL, UIS, SDTH Higher; BEAT, FRPT, RPRX, SPAR Lower
-
Notable Analyst Rating Changes 7/1: YUM, TRW, MGA, MVL Upgraded; FRPT, NDAQ, BEAT, MYGN Downgraded
-
Morning Movers 7/1: OSK, BORL, CBL, LNN Higher; BEAT, FRPT, GSIG, MYGN, IMMR Lower
-
Citi Downgrades CardioNet (BEAT) to Hold
-
Notable Analyst Rating Changes 4/24: RIMM, AMGN, INFA, CAKE Upgraded; MAR, SPWRA, TOL, PTR Downgraded
-
Citi Maintains a 'Buy' on CardioNet (BEAT) After Meeting With Management
-
Citi Upgrades CardioNet (BEAT) to Buy
-
Pre-Open Movers: Focus Media (FMCN) Higher on Results; Hershey (HYS) Lower on Weak Guidance
-
Citi Downgrades CardioNet (BEAT) to Hold
-
Notable Analyst Rating Changes 4/30: BP, CBS, RT Upgraded; TMA, BX, VLO Downgraded
-
Notable Analyst Rating Changes 4/28: LCC, BIG, MRVL Upgraded; MOT, KSS, AIG, BEBE Downgraded
-
Citi Initiates Coverage on CardioNet (BEAT) with a Buy
-
CardioNet (BEAT) Sees New IPO Price of $18-$20
-
CardioNet (BEAT) Sees IPO Price of $22-$24

